MUMBAI: The new IPTV forecast from MRG, Inc. indicates that the number of global IPTV subscribers will grow from 53 million in 2011 to 105.1 million in 2015, a CAGR of 18.7 per cent.
The service revenue for the global IPTV market was $21.8 billion in 2011 and is projected to grow to $45.3 billion in 2015, a CAGR of 20 per cent. By 2015, Europe and North America will continue to generate a larger share of the global revenue. New and innovative services of key Operators described in the report reveal that IPTV operators are aggressively developing these new services to compete with other local Pay-TV operators.
MRG IPTV analyst Jose Alvear said, "In recent quarters, IPTV Operators have seen their subscriber growth outpace that of their Cable and Satellite TV rivals. IPTV Operators are expanding their TV offerings by aggressively adding HD, multiscreen and multiview services, and hybrid services like OTT video linked with Digital Terrestrial or Satellite video services."
Increasingly, IPTV providers are moving away from pure-play IPTV services and are adding new ways to deliver content to their customers.
"Although certain regions and countries have seen very good IPTV subscriber growth, areas like Latin America, and Southeast Asia still have not gotten off the ground with IPTV. As such, IPTV growth will likely be quick once government and regulatory issues have been dealt with."
The IPTV ecosystem breaks into nine industry segments: DSL Subscribers, IPTV Subscribers, Access Systems, Video Headend Encoder Systems, Video-on-Demand Server Software Licenses, Set-top Boxes, Middleware Licenses, Content Protection/Digital Rights Management (CP/DRM) Licenses and System Integration and Professional Services.
Each market segment is split into four regions around the world: Europe, Asia, North America and Rest of World, based on over 930 Service Providers (operators) worldwide offering IPTV services. The number of operators has increased since the last report, since more of them have launched services in the last 12 months or announced new trials.
